IRIS Accounts Production v24.1.0.578 05541548 director 1.2.23 31.1.24 31.1.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh055415482023-01-31055415482024-01-31055415482023-02-012024-01-31055415482022-01-31055415482022-02-012023-01-31055415482023-01-3105541548ns15:EnglandWales2023-02-012024-01-3105541548ns14:PoundSterling2023-02-012024-01-3105541548ns10:Director12023-02-012024-01-3105541548ns10:PrivateLimitedCompanyLtd2023-02-012024-01-3105541548ns10:SmallEntities2023-02-012024-01-3105541548ns10:AuditExemptWithAccountantsReport2023-02-012024-01-3105541548ns10:SmallCompaniesRegimeForDirectorsReport2023-02-012024-01-3105541548ns10:SmallCompaniesRegimeForAccounts2023-02-012024-01-3105541548ns10:AbridgedAccounts2023-02-012024-01-3105541548ns10:RegisteredOffice2023-02-012024-01-3105541548ns5:CurrentFinancialInstruments2024-01-3105541548ns5:CurrentFinancialInstruments2023-01-3105541548ns5:Non-currentFinancialInstruments2024-01-3105541548ns5:Non-currentFinancialInstruments2023-01-3105541548ns5:ShareCapital2024-01-3105541548ns5:ShareCapital2023-01-3105541548ns5:SharePremium2024-01-3105541548ns5:SharePremium2023-01-3105541548ns5:RetainedEarningsAccumulatedLosses2024-01-3105541548ns5:RetainedEarningsAccumulatedLosses2023-01-3105541548ns5:PlantMachinery2023-02-012024-01-3105541548ns5:ComputerEquipment2023-02-012024-01-3105541548ns5:Secured2024-01-3105541548ns5:Secured2023-01-310554154812023-02-012024-01-31
REGISTERED NUMBER: 05541548 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 January 2024

for

Enzyme Supplies Limited

Enzyme Supplies Limited (Registered number: 05541548)






Contents of the Financial Statements
for the Year Ended 31 January 2024




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4

Chartered Accountants' Report 7

Enzyme Supplies Limited

Company Information
for the Year Ended 31 January 2024







DIRECTOR: P I Richards





REGISTERED OFFICE: John Eccles House
Robert Robinson Avenue
The Oxford Science Park
Oxford
Oxfordshire
OX4 4GP





REGISTERED NUMBER: 05541548 (England and Wales)





ACCOUNTANTS: Kenneth Morris Limited
1 Aston Court
Bromsgrove Technology Park
Bromsgrove
Worcestershire
B60 3AL

Enzyme Supplies Limited (Registered number: 05541548)

Abridged Balance Sheet
31 January 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,267 1,689

CURRENT ASSETS
Stocks 148,865 121,994
Debtors 67,870 101,026
Investments 1,500 1,500
Cash at bank 6,105 6,420
224,340 230,940
CREDITORS
Amounts falling due within one year 131,580 124,587
NET CURRENT ASSETS 92,760 106,353
TOTAL ASSETS LESS CURRENT
LIABILITIES

94,027

108,042

CREDITORS
Amounts falling due after more than one year 14,545 25,454
NET ASSETS 79,482 82,588

CAPITAL AND RESERVES
Called up share capital 120 120
Share premium 19,988 19,988
Retained earnings 59,374 62,480
SHAREHOLDERS' FUNDS 79,482 82,588

Enzyme Supplies Limited (Registered number: 05541548)

Abridged Balance Sheet - continued
31 January 2024


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Balance Sheet for the year ended 31 January 2024 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 10 April 2024 and were signed by:





P I Richards - Director


Enzyme Supplies Limited (Registered number: 05541548)

Notes to the Financial Statements
for the Year Ended 31 January 2024

1. STATUTORY INFORMATION

Enzyme Supplies Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance
Computer equipment - 33% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign exchange
Transactions denominated in foreign currencies are translated into sterling and recorded at the rate of exchange ruling at the date of the transaction. Balances at the year-end denominated in a foreign currency are translated into sterling at the rate of exchange ruling at the balance sheet date.

Enzyme Supplies Limited (Registered number: 05541548)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2024

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Investments
Listed investments are included at fair value. Investments in unlisted shares are included at historical cost.

Debtors
Factored debts are included on the balance sheet within debtors. The proceeds received from the factor are included as secured liabilities. Factoring charges are recognised as they accrue and included within interest payable and similar charges.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 February 2023
and 31 January 2024 32,278
DEPRECIATION
At 1 February 2023 30,589
Charge for year 422
At 31 January 2024 31,011
NET BOOK VALUE
At 31 January 2024 1,267
At 31 January 2023 1,689

5. SECURED DEBTS

The following secured debts are included within creditors:

2024 2023
£    £   
Bank overdraft 6,677 -
Bank loans 25,454 36,363
Invoice Discounting Finance 16,148 21,058
Funding Circle Loan - 2,038
48,279 59,459

Ultimate Invoice Finance Limited hold a fixed and floating charge over assets dated 22 June 2017. The bank overdraft is secured by a personal guarantee from the director.

Enzyme Supplies Limited (Registered number: 05541548)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2024

6. CONTINGENT LIABILITIES

There are no contingent liabilities.

7. POST BALANCE SHEET EVENTS

There are no known material post balance sheet events.

Chartered Accountants' Report to the Director
on the Unaudited Financial Statements of
Enzyme Supplies Limited

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Abridged Statement of Comprehensive Income and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Enzyme Supplies Limited for the year ended 31 January 2024 which comprise the Abridged Income Statement, Abridged Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the director of Enzyme Supplies Limited in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Enzyme Supplies Limited and state those matters that we have agreed to state to the director of Enzyme Supplies Limited in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Enzyme Supplies Limited and its director for our work or for this report.

It is your duty to ensure that Enzyme Supplies Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Enzyme Supplies Limited. You consider that Enzyme Supplies Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Enzyme Supplies Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Kenneth Morris Limited
1 Aston Court
Bromsgrove Technology Park
Bromsgrove
Worcestershire
B60 3AL


10 April 2024